Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

IMELDA CITLADI TOLEDO-NEELY

Allopathic & Osteopathic Physicians Family Medicine

NPI
1073593281
CMS profile
650135
Location
LAS CRUCES, NM

General Payments · PY2018–2024

$7,808.39

  • Reported across 348 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,252.62

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,252.62 34

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $530.64 14
Lilly USA, LLC $162.55 7
ABIOMED $147.30 1
Abbott Laboratories $133.10 1
Novo Nordisk AS $91.22 1
Insulet Corporation $62.65 3
GlaxoSmithKline, LLC. $34.80 2
Organon LLC $21.49 1
Boehringer Ingelheim Pharmaceuticals, Inc. $18.69 1
Amgen Inc. $18.61 1
Vanda Pharmaceuticals Inc. $16.05 1
Exact Sciences Corporation $15.52 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,507.84 124
PY2019 $1,335.00 67
PY2020 $854.51 44
PY2021 $506.44 22
PY2022 $546.61 27
PY2023 $805.37 30
PY2024 $1,252.62 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $133.10 12/19/2024 Food and Beverage Undisputed 01/23/2026 1124826107 CMS
ABIOMED $147.30 12/04/2024 Food and Beverage Undisputed 01/23/2026 1142275689 CMS
Amgen Inc. $18.61 07/17/2024 Food and Beverage Undisputed 01/23/2026 1117399520 CMS
AstraZeneca Pharmaceuticals LP $19.06 01/04/2024 Food and Beverage Undisputed 01/23/2026 1104733875 CMS
AstraZeneca Pharmaceuticals LP $20.59 01/31/2024 Food and Beverage Undisputed 01/23/2026 1104209495 CMS
AstraZeneca Pharmaceuticals LP $106.16 02/07/2024 Food and Beverage Undisputed 01/23/2026 1105426187 CMS
AstraZeneca Pharmaceuticals LP $110.95 02/13/2024 Food and Beverage Undisputed 01/23/2026 1104513506 CMS
AstraZeneca Pharmaceuticals LP $21.51 03/14/2024 Food and Beverage Undisputed 01/23/2026 1105625799 CMS
AstraZeneca Pharmaceuticals LP $14.58 03/20/2024 Food and Beverage Undisputed 01/23/2026 1104318484 CMS
AstraZeneca Pharmaceuticals LP $15.90 03/25/2024 Food and Beverage Undisputed 01/23/2026 1105526117 CMS
AstraZeneca Pharmaceuticals LP $111.31 04/05/2024 Food and Beverage Undisputed 01/23/2026 1105605379 CMS
AstraZeneca Pharmaceuticals LP $14.30 05/29/2024 Food and Beverage Undisputed 01/23/2026 1105813901 CMS
AstraZeneca Pharmaceuticals LP $14.32 08/13/2024 Food and Beverage Undisputed 01/23/2026 1105658860 CMS
AstraZeneca Pharmaceuticals LP $18.90 10/30/2024 Food and Beverage Undisputed 01/23/2026 1104575724 CMS
AstraZeneca Pharmaceuticals LP $15.49 11/07/2024 Food and Beverage Undisputed 01/23/2026 1104200723 CMS
AstraZeneca Pharmaceuticals LP $29.74 12/04/2024 Food and Beverage Undisputed 01/23/2026 1105295411 CMS
AstraZeneca Pharmaceuticals LP $17.83 12/12/2024 Food and Beverage Undisputed 01/23/2026 1104205871 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.69 01/17/2024 Food and Beverage Undisputed 01/23/2026 1117862261 CMS
Exact Sciences Corporation $15.52 02/27/2024 Food and Beverage Undisputed 01/23/2026 1114932778 CMS
GlaxoSmithKline, LLC. $20.05 05/10/2024 Food and Beverage Undisputed 01/23/2026 1116719272 CMS
GlaxoSmithKline, LLC. $14.75 09/19/2024 Food and Beverage Undisputed 01/23/2026 1115769985 CMS
Insulet Corporation $21.74 01/25/2024 Food and Beverage Undisputed 01/23/2026 1116793156 CMS
Insulet Corporation $17.97 01/30/2024 Food and Beverage Undisputed 01/23/2026 1116793136 CMS
Insulet Corporation $22.94 11/19/2024 Food and Beverage Undisputed 01/23/2026 1116823306 CMS
Lilly USA, LLC $19.67 02/14/2024 Food and Beverage Undisputed 01/23/2026 1134985446 CMS
Lilly USA, LLC $16.89 04/24/2024 Food and Beverage Undisputed 01/23/2026 1135007353 CMS
Lilly USA, LLC $2.93 05/14/2024 Food and Beverage Undisputed 01/23/2026 1135033634 CMS
Lilly USA, LLC $11.98 05/15/2024 Food and Beverage Undisputed 01/23/2026 1135007355 CMS
Lilly USA, LLC $66.53 05/15/2024 Food and Beverage Undisputed 01/23/2026 1135026824 CMS
Lilly USA, LLC $19.28 08/29/2024 Food and Beverage Undisputed 01/23/2026 1135026826 CMS
Lilly USA, LLC $25.27 10/24/2024 Food and Beverage Undisputed 01/23/2026 1135009101 CMS
Novo Nordisk Inc $91.22 03/05/2024 Food and Beverage Undisputed 01/23/2026 1097659156 CMS
Organon Llc $21.49 10/08/2024 Food and Beverage Undisputed 01/23/2026 1136195066 CMS
Vanda Pharmaceuticals Inc. $16.05 08/06/2024 Food and Beverage Undisputed 01/23/2026 1133923243 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.